What is the recommended management of hyperglycemia in adult inpatients, including both ICU and non‑ICU settings?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Hyperglycemia During Admission

For hospitalized adults with hyperglycemia, initiate insulin therapy when blood glucose persistently exceeds 180 mg/dL, targeting 140-180 mg/dL for both ICU and non-ICU patients, using continuous IV insulin in critically ill patients and basal-bolus subcutaneous regimens in non-critically ill patients. 1

Blood Glucose Targets

ICU/Critically Ill Patients

  • Start insulin therapy at glucose ≥180 mg/dL (checked on two occasions) 1
  • Target range: 140-180 mg/dL (7.8-10.0 mmol/L) for the majority of critically ill patients 2, 1
  • More stringent targets of 110-140 mg/dL may be considered for:
    • Cardiac surgery patients
    • Post-surgical ICU patients
    • Centers with extensive experience and robust nursing support
    • Only if achievable without significant hypoglycemia risk 2, 1

The shift away from aggressive euglycemic control stems from the landmark NICE-SUGAR trial (2009), which demonstrated increased mortality with intensive insulin therapy targeting lower glucose levels, primarily due to iatrogenic hypoglycemia 2.

Non-ICU/General Medicine and Surgery Patients

  • Start insulin therapy at glucose ≥180 mg/dL (persistent elevation) 1
  • Target range: 140-180 mg/dL for most patients 1
  • Alternative acceptable range: 100-180 mg/dL for noncritically ill patients, particularly those with new hyperglycemia 1
  • Pre-meal targets: <140 mg/dL
  • Random glucose targets: <180 mg/dL 2

Important caveat: Higher glucose ranges up to 200-250 mg/dL may be acceptable in terminally ill patients or those with severe comorbidities where aggressive control risks outweigh benefits 2, 1.

Insulin Delivery Methods

ICU Setting

Continuous intravenous insulin infusion is the preferred regimen for: 2

  • All critically ill patients with hyperglycemia (with or without diabetes diagnosis)
  • Patients with hyperglycemic crises (DKA, HHS)
  • Severe steroid-induced hyperglycemia
  • Solid organ transplant recipients

This approach allows rapid titration and adjustment to changing patient physiology during critical illness.

Non-ICU Setting

Basal-bolus subcutaneous insulin regimens are preferred for patients with good nutritional intake, consisting of: 3

  • Basal insulin: Long-acting insulin (once or twice daily)
  • Prandial/nutritional insulin: Rapid-acting insulin before meals
  • Correction insulin: Supplemental rapid-acting insulin for hyperglycemia

For patients with poor or no oral intake:

  • Single dose of long-acting basal insulin plus correction insulin as needed 3
  • Avoid basal-bolus regimens in NPO patients to prevent hypoglycemia

Critical pitfall: Sliding-scale insulin as sole therapy is discouraged and should not be used 4, 5. It is reactive rather than proactive and fails to address basal insulin needs.

Glucose Monitoring

Frequency

  • Patients eating: Point-of-care glucose monitoring before each meal 1
  • Patients not eating (NPO): Every 4-6 hours 1
  • Patients on IV insulin: Every 30 minutes to 2 hours (required standard for safety) 1

Monitoring Considerations

Point-of-care capillary glucose meters are less accurate than laboratory analyzers and can be affected by:

  • Poor perfusion
  • Edema
  • Anemia/erythrocytosis
  • Certain medications 1

Continuous glucose monitoring (CGM) provides more comprehensive glycemic assessment and enhances hypoglycemia prevention in high-risk hospitalized patients 6.

Special Considerations

Hyperglycemic Crises (DKA/HHS)

  • Moderate-to-severe DKA: Continuous IV insulin infusion mandatory 2
  • Mild-to-moderate DKA: May use frequent subcutaneous insulin injections 2
  • Monitor potassium closely: Hypokalaemia occurs in ~50% of cases; severe hypokalaemia (<2.5 mEq/L) increases mortality 2

Cardiac Surgery and Ischemic Events

Lower glucose targets (100-140 mg/dL) may improve outcomes in cardiac surgery patients, though intensive lowering in acute ischemic events (MI, stroke) has not shown additional benefit and increases hypoglycemia risk 2.

Admission Assessment

Measure hemoglobin A1c at admission to assess pre-existing glycemic control and tailor discharge treatment regimens 3.

Key Safety Principles

Hypoglycemia is the primary limiting factor in achieving optimal glycemic targets and is an independent risk factor for poor outcomes 5. The 10- to 15-fold increase in hypoglycemia rates with intensive control in NICE-SUGAR likely contributed to increased mortality 1.

To minimize hypoglycemia risk:

  • Avoid glucose targets <110 mg/dL in most patients
  • Use institutional insulin algorithms and preprinted order sets
  • Implement hypoglycemia protocols
  • Adjust insulin doses based on nutritional intake changes
  • Consider clinical trajectory, illness severity, and concurrent medications (especially glucocorticoids) 1

References

2
Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

4
Research

Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2010

5
Research

Glycemic management in the inpatient setting.

Hospital practice (1995), 2012

Related Questions

How should hyperglycemia be managed in a patient who must fast for a laboratory test?
What is the recommended management of acute hyperglycemia upon hospital admission?
What is the appropriate management for a patient whose blood glucose was 404 mg/dL before receiving insulin?
How do I calculate a correction (rescue) dose of regular insulin for hyperglycemic episodes based on a patient’s total daily insulin requirement?
What immediate management steps should be taken for a patient with hyperglycemia (blood glucose 340 mg/dL in the afternoon and 436 mg/dL in the evening) who is on Mixtard (insulin human mixture) 36 units in the morning, 0 units at midday, and 32 units at night?
Which reimbursable hypnotic medications are appropriate for treating sleep‑onset insomnia in an adult patient?
What is the recommended dalbavancin dosing regimen for an adult with proven or strongly suspected Gram‑positive osteomyelitis, and how should the dose be adjusted in renal impairment?
Is clonidine safe for patients with cardiac disease?
Can kidney pain radiate down to the legs and reach the knees?
What is the safest pharmacologic sleep aid for a patient receiving hydromorphone?
Which medications should I request at the pharmacy to promote rapid sleep onset and maintain sleep throughout the night?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.